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The herpes simplex virus 2 (HSV-2) virion host shutoff (vhs) protein is a ribonuclease contained in the virion tegument. vhs-deficient
mutants of HSV-2 are profoundly attenuated in vivo, and we have previously shown that replication and virulence of vhs-deficient HSV-2 are
largely restored to levels of wild-type virus in mice lacking the interferon alpha/beta receptor (IFNahR/). This result demonstrated that
HSV-2 vhs interferes with the type I IFN response, but whether vhs inhibits production of type I IFN or synthesis or function of key
mediators of the IFN-induced antiviral state was not clear. Here we address these questions using primary murine embryonic fibroblasts
(MEFs), which produce and respond to IFNah. The vhs-deficient HSV-2 strain 333d41 replicated similarly to wild-type virus (333 clone
SB5) and vhs rescue virus (333d41R) after infection of MEFs at high moi, but at low moi, 333d41 replication was severely attenuated,
recapitulating the attenuated phenotype of vhs-deficient HSV-2 in vivo. Replication of 333d41 at low moi was restored to levels of wild-type
virus in MEFs lacking the IFNah receptor or when IFNah was neutralized, thus establishing the IFNah response as the sole mechanism
attenuating vhs-deficient HSV-2 replication in MEFs. MEFs infected with 333d41 produced >50-fold more IFNah than cells infected with
333 and 333d41R. Pretreatment of MEFs with type I IFN inhibited replication of 333d41 more than 333 and 333d41R, indicating that vhs also
interferes with activation of the IFNah-induced antiviral response. We therefore examined vhs interference with PKR and RNase L, two key
mediators of the IFNah response. 333d41 replication was restored to wild-type levels after low moi infection of PKR/ and RNase L/
MEFs, and was not inhibited in PKR/ MEFs pretreated with IFNa. Together, these observations indicate that HSV-2 vhs is a broad and
potent countermeasure to the IFN-mediated antiviral response in IFN-naı¨ve and -sensitized MEFs.
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Herpes simplex virus type 2 (HSV-2) is the principal
causative agent of genital herpes. HSV-2 infections initiate
in the genital epithelium and rapidly spread into sensory
nerves innervating the mucosa. Innate immune responses,
including the type I interferon (IFNah) response, are the
host’s first line of defense against viruses during this period
of acute infection. IFNah synthesis by cells within hours of
virus infection prepares neighboring uninfected cells to
enter a protective antiviral state. Several lines of evidence
demonstrate the importance of IFNah in restraining acute0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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E-mail address: morrisla@slu.edu (L.A. Morrison).HSV infection. For example, pretreatment of cells with type
I IFNs limits immediately early (a) gene expression (Klotz-
bucher et al., 1990; Mittnacht et al., 1988; Oberman and
Panet, 1988, 1989). IFNah transgene expression reduces
viral yield in cultured cells (Harle et al., 2002a, 2002b;
Noisakran et al., 2000) and limits replication and enhances
survival in mice after HSV-1 and HSV-2 infection (Harle et
al., 2001; Noisakran et al., 1999). Finally, administration of
IFNah-neutralizing antibodies during ocular infection of
mice results in a 1000-fold increase in HSV-1 titers shed
from the cornea (Hendricks et al., 1991; Lausch et al., 1991;
Su et al., 1990). However, HSV strongly resists the effects
of IFNah compared with viruses such as vesicular stoma-
titis virus (VSV), signifying that HSV has evolved mecha-
nisms for evading the IFNah response (Harle et al., 2002b;
Mossman et al., 2000; Taylor et al., 1998).
IFNah production is stimulated by cellular transcrip-
tion factors activated by virus infection (Levy and Garcia-
Fig. 1. Replication of 333d41 is reduced during low moi infection of 129
MEFs. 129MEFswere infected at anmoi of 10 (A) or 0.1 (B) with 333(SB5),
333d41, 333d41R, or DTK. Cultures were harvested at progressive time
points postinfection. Viral titers were determined by standard plaque assay on
Vero cells. Data points are the geometric meanF SEM of duplicate wells and
are from one of three independent experiments. P < 0.0001 for 333 compared
with 333d41 at 16–48 h postinfection at low moi.
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lates signal transduction through phosphorylation of
IFNahR-associated Jak/STAT molecules. The ISGF3 com-
plex formed translocates to the nucleus and binds ISRE
sequences to activate transcription of genes involved in
antiviral defense, the best characterized of which are
protein kinase RNA-activated (PKR) and RNase L. Upon
subsequent infection of the IFN-primed cell, viral double-
stranded RNA (dsRNA) triggers activation of the antiviral
state. dsRNA activates PKR to phosphorylate eIF2a, and
induces synthesis of 2V5Voligoadenylates that activate RNase
L. These cause translational arrest and RNA degradation,
respectively, resulting in inhibition of macromolecular syn-
thesis in the infected cell.
PKR and RNase L play important roles in the antiviral
response to HSV. Replication of HSV-1 in PKR/ murine
embryonic fibroblasts (MEFs) is increased by 5- to 250-fold
compared to replication in wild-type cells, and IFNa pre-
treatment of wild-type but not PKR/ MEFs suppresses
HSV-1 replication (Khabar et al., 2000). HSV-1 replication
also increases 14-fold in RNase L/ MEFs (Harle et al.,
2002b). The apparent capacity of PKR to inhibit HSV
replication is reduced by two HSV-encoded proteins,
ICP34.5 and Us11, which direct dephosphorylation of
eIF2a and bind PKR, respectively (Cassady et al., 1998a;
He et al., 1997). HSV-1 deficient in ICP34.5 is attenuated in
wild-type mice (Leib et al., 2000), and the effect of deleting
Us11 from a g34.5 virus causes further attenuation (S.
Ward and D. Leib, personal communication). In addition,
2V5V A derivatives that may antagonize RNase L activation
are produced during HSV infection (Cayley et al., 1984),
although the importance of this mechanism to in vivo
infection has not been demonstrated. Initial production of
type I IFNs is also reduced by HSV-1 ICP0 interference with
the activation and nuclear translocation of IRF-3 (Eidson et
al., 2002; Lin et al., 2004), and an ICP0-deficient mutant of
HSV-1 replicates to higher titers in IFNahR/ mice than
wild-type mice (Leib et al., 1999). The multiple IFN-
regulatory proteins encoded by HSVattest to the importance
of inhibiting this innate host response to infection.
In contrast to HSV-encoded proteins that target specific
steps in the IFN response pathways, the HSV-2 virion host
shutoff (vhs) protein may represent a relatively nonspecific
countermeasure. The HSV vhs protein, encoded by the
UL41 gene (Oroskar and Read, 1989), is carried in the
tegument layer of the virion (Fenwick and Clark, 1982;
Read and Frenkel, 1983) and immediately degrades mRNA
following its release into the cytoplasm of the infected cell
(Kwong and Frenkel, 1987, 1989; Oroskar and Read, 1989;
Read and Frenkel, 1983). Though vhs-deficient mutants of
HSV replicate normally in Vero cells, they replicate poorly
in vivo and are reduced in virulence (Smith et al., 2000,
2002; Strelow and Leib, 1995; Strelow et al., 1997). We
have shown that HSV-2 vhs-deficient mutants are restored
nearly to the virulence of wild-type HSV-2 in IFNahR/
mice (Murphy et al., 2003). This result indicates that theHSV-2 vhs protein interferes with the type I IFN response in
vivo, and is consistent with the rapid attenuation of vhs
mutants and the significant role of type I IFN in the innate
response to virus infections. Because vhs is a ribonuclease,
it has the potential to broadly inhibit the IFNah response,
but whether vhs prevents synthesis of IFNah or IFN-
stimulated gene products is unknown. We therefore inves-
tigated which phase(s) of the type I IFN antiviral response
HSV-2 vhs interferes with by infecting cultured primary
MEFs, which both synthesize and respond to IFNah, with
wild-type and vhs-deficient HSV-2 strains.Results
In vitro reproduction of vhs-deficient virus attenuation
To establish a murine culture system in which replication
of vhs-deficient HSV-2 would be sensitive to IFNah, we
Fig. 4. More IFNah is produced by MEFs infected with 333d41 than wild-
type virus. Supernatant samples were taken in triplicate from 129 MEFs
infected with 333(SB5), 333d41, or 333d41R. Samples were serially diluted
and incubated with L929 cells for 24 h. Following incubation, cells were
challenged with 3.6  102 pfu/ml VSV for 48 h. Cells were then stained
with Giemsa and OD was quantitated at 570 nm. Units of IFN produced
were determined from a standard curve generated from IFN standards. Data
represent the geometric mean F SEM of duplicate wells and are from one
of two independent experiments.
Fig. 2. Replication of 333d41 during low moi infection is restored in
IFNahR/ MEFs. IFNahR/ MEFs (129 background) were infected at
an moi of 10 (A) or 0.1 (B) with 333(SB5), 333d41, 333d41R, or DTK.
Cultures were harvested at progressive time points postinfection. Viral titers
were determined by standard plaque assay on Vero cells. Data points are the
geometric mean F SEM of duplicate wells and are from one of three
independent experiments.
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IFN) at various multiplicities. We reasoned that during high
moi infection, all cells in culture would be infected by virus,Fig. 3. Replication of 333d41 is restored at low moi with IFNah-neutralizing
polyclonal sheep anti-mouse IFNah antibodies were included or mock-included in
as negative controls. Cultures were harvested at 30 h postinfection. Viral titers w
geometric mean F SEM of duplicate wells and are from one of two independentso any IFNah produced could not protect the cells from
infection. During low moi infection, IFNah produced by
infected cells could signal uninfected cells to prime for a
protective antiviral state. Because wild-type HSV-2 but not
vhs-deficient virus interferes with the type I IFN response inantibodies. 129 MEFs were infected at an moi of 0.1. Serial dilutions of
the postinfection medium. Anti-IFNg antibodies and sheep IgG were used
ere determined by standard plaque assay on Vero cells. Data represent the
experiments.
Fig. 5. Replication of 333d41 is more sensitive to IFN pretreatment than 333 in wild-type MEFs. Wild-type 129 MEFs were mock-treated or pretreated
for 24 h with 100 or 1000 IU/ml murine IFNaA or IFNh. Cells were then infected with 333(SB5), 333d41, 333d41R, or DTK. Cultures were harvested at
24 h postinfection. Viral titers were determined by standard plaque assay on Vero cells. Data represent the geometric mean F SEM of duplicate wells and
are from one of three independent experiments.
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moi infection of MEFs. To test this hypothesis, 129 MEFs
were infected at high moi (10 pfu/cell) or low moi (0.1 pfu/
cell) with wild-type HSV-2 (333 clone SB5), vhs-deficient
(333d41), or vhs rescue (333d41R) viruses, and cultures
were harvested at progressive times postinfection. 333d41
replicated similarly to wild-type virus at high moi (Fig. 1A),Fig. 6. Replication of 333d41 is restored after low moi infection of PKR/MEFs.
moi of 10 (A and B) or 0.1 (C and D) with 333(SB5), 333d41, or 333d41R. Cultu
determined by standard plaque assay on Vero cells. Data points are the geometric mbut replicated to approximately 100-fold lower titers than
333 and 333d41R at low moi (Fig. 1B). A 333 strain with a
deletion in the thymidine kinase locus, 333DTK, replicated
similarly to wild-type virus after infection at high and low
moi, indicating that attenuated growth after low moi infec-
tion was specific to the vhs deletion and was not a general
property of mutants showing attenuated phenotypes in vivo.Wild-type 129 (A and C) and PKR/ (B and D) MEFs were infected at an
res were harvested at progressive time points postinfection. Viral titers were
eanF SEM of duplicate wells and are one of two independent experiments.
Fig. 7. 333d41 replication is restored in PKR/ but not RNase L/MEFs
pretreated with IFN. Wild-type 129 (A) and congenic PKR/ (B) MEFs
were mock-treated or pretreated for 24 h with 100 or 1000 IU/ml murine
IFNaA. Cells were then infected with 333(SB5), 333d41, 333d41R, or
DTK. Cultures were harvested at 24 h postinfection. Viral titers were
determined by standard plaque assay on Vero cells. Data represent the
geometric mean F SEM of duplicate wells and are from one of two
independent experiments.
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high moi infection of HaCAT cells, a human keratinocyte
cell line that produces and responds to IFNah (data not
shown).
To determine whether attenuation of vhs-deficient virus
in MEFs infected at low moi was IFNah-dependent, we
measured viral replication in MEFs lacking the IFNah
receptor. Because these cells cannot respond to type I
IFN, priming for an antiviral state after low moi infection
cannot occur. Thus, the vhs protein would not be needed to
counteract an IFN-induced response, and vhs-deficient virus
should replicate equivalently to wild-type virus at both high
and low moi. In IFNahR/ MEFs (129 background),
replication of 333d41 was similar to replication of 333
and 333d41R at high moi (Fig. 2A), and low moi (Fig.
2B). All viruses also replicated to similar titers after low moi
infection of Vero cells, which do not produce IFNah (data
not shown). These results are consistent with the idea that
more type I IFN was made during 333d41 infection, which
protected uninfected cells from virus spread during low moi
infection. They are also consistent with the possibility that
vhs-deficient virus failed to efficiently inhibit induction or
activation of the antiviral state in IFN-primed cells.
To determine whether IFNah was specifically responsi-
ble for the attenuated growth of vhs-deficient virus during
low moi infection of wild-type MEFs, we measured viral
replication when IFNah was neutralized by addition of
sheep polyclonal anti-IFNah antibodies. 129 MEFs were
infected at low moi, and increasing concentrations of anti-
IFNah Abs were included or mock included in the postin-
fection medium. Cultures were harvested 30 h postinfection.
Inclusion of IFNah Abs effectively restored replication of
333d41 to the levels of 333, 333d41R, and 333DTK in a
dose-dependent manner (Fig. 3). 333d41 remained attenu-
ated in mock-treated cells, as well as in cells treated with
polyclonal sheep IgG or anti-IFNg antibodies. The results
indicate that replication of vhs-deficient virus is specifically
inhibited by IFNah produced by infected MEFs. They also
demonstrate that MEFs infected at low moi accurately
reproduce vhs-deficient virus attenuation and IFN sensitiv-
ity observed in vivo.
Effect of vhs on IFNab production
To determine whether vhs interferes with IFNah synthe-
sis, IFNah production was measured during infection with
wild-type virus or vhs-deficient virus using a standard
bioassay. L929 cells were incubated with serial dilutions
of supernatants from infected 129 MEFs and then were
challenged by infection with vesicular stomatitis virus
(VSV) for 48 h. The cells were stained and the proportion
of the monolayers protected by IFN was quantitated by
measuring optical density. Concentration of IFN in the
supernatants was determined by comparison to a standard
curve generated using purified recombinant IFNa and
IFNh. Supernatants from MEFs infected for 12 h with333d41 contained approximately 22-fold more IFNah than
supernatants from MEFs infected with 333 or 333d41R (Fig.
4A; P = 0.0077 for 333 v. 333d41), and 58-fold more
IFNah by 24 h postinfection (Fig. 4B; P = 0.0006). Thus,
more type I IFN was produced during vhs-deficient HSV-2
infection than infection with wild-type or vhs rescue viruses,
indicating that vhs dramatically limits IFNah production.
Effect of vhs on activation of the IFN-induced antiviral
response
To determine whether vhs inhibits activation of IFN-
induced antiviral pathways in cells previously primed by
IFNah receptor signaling, 129 MEFs were mock-treated or
pretreated with murine IFNaA or murine IFNh (100 or
1000 IU/ml) for 24 h, then were washed and infected at an
moi of 10. Cultures were harvested 24 h postinfection and
virus titer was determined. Replication of 333 and 333d41R
was reduced approximately twofold and ninefold after
pretreatment with 100 IU of IFNaA or IFNh, respectively,
consistent with previous findings (Harle et al., 2002b;
Taylor et al., 1998). In contrast, replication of 333d41 was
reduced 46-fold by IFNaA pretreatment and 58-fold by
pretreatment with IFNh (P < 0.005 for 333d41 compared
with 333) (Fig. 5). Replication of 333DTK in IFN-pre-
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decreased capacity to counteract activation of the antiviral
state was specific to the vhs mutation. Titers for all viruses
were equivalent in IFNahR/ MEFs regardless of IFN
pretreatment (data not shown). Replication of VSV, which is
exquisitely sensitive to IFN, was reduced below the limit of
detection by IFN pretreatment (data not shown). These
experiments demonstrate that cell priming by IFNah expo-
sure diminishes replication of vhs-deficient virus; wild-type
virus containing a functional vhs protein is able to interfere
with activation of the IFN-induced antiviral response.
Role of vhs in inhibition of PKR
PKR, a principal effector molecule in one of the major
IFN-induced antiviral pathways, phosphorylates eIF2a to
cause translational arrest. To determine the effect of vhs on
the PKR pathway, viral replication was measured after high
and low moi infection of wild-type MEFs or MEFs derived
from mice genetically deficient in PKR. 333d41 replicated
like 333 and 333d41R after high moi infection of 129 and
PKR/ MEFs (Figs. 6A and B), as expected given theFig. 8. Replication of 333d41 is restored after low moi infection of RNase L/M
infected at an moi of 10 (A and B) or 0.1 (C and D) with 333(SB5), 333d41, or 333
titers were determined by standard plaque assay on Vero cells. Data points are
independent experiments.premise that all cells are initially infected and the antiviral
state cannot be imposed in time to influence virus replica-
tion. After low moi infection, 333d41 showed a growth
deficit compared to 333 and 333d41R in wild-type MEFs
(Fig. 6C; P < 0.0001 at 12–36 h postinfection), but did not
in PKR/ MEFs (Fig. 6D). Restoration of 333d41 growth
in the absence of PKR suggests that vhs interferes with
induction or activation of the PKR-mediated antiviral re-
sponse in MEFs.
To assess vhs effects on activation of the PKR pathway,
wild-type and PKR/ MEFs were pretreated with IFNaA
or IFNh as described above and infected for 24 h before
determination of virus titer. Replication of 333d41 was
limited more significantly than wild-type virus in IFN-pre-
treated 129 MEFs (37-fold versus 1.3-fold, respectively, at
the 100 IU/ml dose; P = 0.0003) (Fig. 7A), but recovered to
virtually wild-type levels in IFNa-treated MEFs lacking
PKR (Fig. 7B). Thus, activation of the PKR pathway exerts
a potent antiviral effect that is more successfully counter-
acted by wild-type HSV-2 than vhs-deficient virus. Interest-
ingly, vhs-deficient virus replication did not fully recover to
wild-type levels in PKR/ MEFs treated with IFNh atEFs. Wild-type C57BL/6 (A and C) and RNase L/ (B and D) MEFs were
d41R. Cultures were harvested at progressive time points postinfection. Viral
the geometric mean F SEM of duplicate wells and are from one of two
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additional PKR-independent antiviral pathway normally
inhibited by vhs.
Effect of vhs on RNase L
RNase L, a cellular ribonuclease activated by virus
infection, is also a key mediator of the IFN-induced antiviral
response. Therefore, we determined the effect of vhs on the
RNase L pathway. Wild-type B6 and RNase L/ MEFs
were infected at high and low moi as described above. After
infection of wild-type B6 MEFs at high moi, 333d41
replicated similarly to 333 and 333d41R (Fig. 8A). In RNase
L/ MEFs infected at high moi, replication of wild-type
virus was surprisingly restricted, and titers of vhs-deficient
virus did not increase over the course of infection (Fig. 8B;
P < 0.0021 for 333d41 compared with 333). After low moi
infection of B6 MEFs, the titer of 333d41 was reduced 100-
fold compared with 333 (Fig. 8C; P = 0.0038 for 36
h postinfection). This growth deficit was largely repaired
by infection of RNase L/ MEFs (Fig. 8D), though
replication of all viruses reached a plateau by approximately
24 h postinfection. The results of low moi infections suggest
that during the IFN-induced antiviral response, inhibition of
HSV replication by activation of the RNase L pathway is
prevented by vhs. Ribonuclease activity of HSV-2 vhs in
wild-type and RNase L/ MEFs was similar, as assessed
by Northern analysis of GAPDH mRNA (R.J. Duerst and
T.J. Smith, unpublished observation), disputing the possible
interpretation that HSV-2 infection at high moi stimulates
additional host shutoff activity by activating RNase L to
benefit virus replication.
We similarly determined whether vhs affects RNase L
activation by IFNah pretreatment of wild-type B6 and
RNase L/ MEFs. Because 333d41 replicated almost
equivalently to wild-type virus during low moi infection
of RNase L/ MEFs, we anticipated that the RNase L/
phenotype would permit restoration of 333d41 growth after
IFNaA pretreatment. However, 333d41 did not recover
wild-type levels of replication in RNase L/ MEFs pre-
treated with IFNaA (data not shown). Thus, apparently, in
IFN-pretreated MEFs, vhs-deficient virus is attenuated by
activation of an RNase L-independent antiviral function.Discussion
We have recently shown that vhs-deficient HSV-2, which
is markedly attenuated in normal mice, is restored to the
virulence of wild-type virus in mice lacking the IFNahR
(Murphy et al., 2003). We have now established an in vitro
culture system that reproduces vhs-deficient virus attenua-
tion in an IFNah-dependent manner. Using this system, we
demonstrate that vhs strongly inhibits IFN production and
suppresses IFN-induced antiviral activity in fibroblasts, thus
identifying HSV-2 vhs as a promiscuous inhibitor of thetype I IFN response. It is significant that vhs contributes
strongly to the type I IFN resistance of HSV-2 even in the
apparent company of other resistance mechanisms encoded
by the virus; HSV-1 ICP0, ICP34.5, and Us11 all have been
identified as inhibitors of specific steps in the IFNah
response to HSV-1 (Cassady et al., 1998b; Eidson et al.,
2002; Harle et al., 2002c; He et al., 1997; Leib et al., 2000).
Nevertheless, vhs-deficient HSV-2 still has significant ca-
pacity to counteract the IFN-induced antiviral response
because IFN pretreatment of MEFs did not inhibit vhs-
deficient HSV-2 replication as completely as VSV. One or
more of these additional anti-IFN proteins may mediate the
residual resistance of vhs-deficient HSV-2 to the type I IFN
response. The relationship of HSV-2 vhs to other mediators
of HSV IFN resistance is of considerable interest.
Our studies demonstrate a predominant role for antiviral
effects exerted by the PKR pathway in attenuation of vhs-
deficient virus. HSV-1 Us11 and ICP34.5 are specific
inhibitors of PKR activity. Here we show that HSV-2 vhs
also inhibits the PKR pathway in MEFs. Evidence for this
includes restoration of vhs-deficient virus replication in
PKR/ MEFs infected at low moi and in PKR/ MEFs
pretreated with IFNa. Attenuation of vhs-deficient virus by
a PKR-dependent mechanism could be due to a greater
amount of activated PKR in vhs-deficient virus-infected
cells, but our results do not preclude the possibility that
vhs interferes with induction or activation of other mem-
ber(s) of the PKR response pathway. The addition of HSV-2
vhs-mediated inhibition of the PKR pathway to the PKR
inhibitory activities of ICP34.5 and Us11 implies that HSV
places great significance on neutralizing this antiviral re-
sponse in MEFs.
Despite restoration of vhs-deficient virus replication in
PKR/ MEFs, we previously found that replication and
virulence of vhs-deficient virus is not restored in PKR/
mice (Murphy et al., 2003). Differential stimulation of
various antiviral pathways by IFN in the variety of cell
types infected in vivo may explain the apparent discrepancy
in the role of vhs as an inhibitor of the PKR pathway in mice
versus MEFs. Cell types infected in the genital mucosa and
nervous system may be less reliant on PKR than MEFs to
achieve the antiviral state. PKR/ mice may thus retain the
ability to suppress replication of vhs-deficient virus. Alter-
natively, initial synthesis of IFNah may require preformed
PKR in MEFs but not in cells infected in vivo. Either of
these mechanisms could circumvent the need for PKR to
attain an antiviral effect. Additionally, our MEF model
differs from our in vivo observations in that although vhs-
deficient virus replicates to the same level as wild-type virus
in IFNahR/ MEFs, replication in the genital epithelium
of IFNahR/ mice is restored only over the first 2 days
postinfection (Murphy et al., 2003). In vivo, vhs-deficient
virus may be less equipped to avoid other immune media-
tors that also participate in limiting HSV replication.
Whereas vhs counteracts the PKR pathway in MEFs,
the relationship between vhs and RNase L is less clear.
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after low moi infection of RNase L/ MEFs than B6
MEFs. Nevertheless, vhs-deficient virus was attenuated
relative to wild-type virus in RNase L/ cells pretreated
with type I IFN. During low moi infections, virus may
spread in the culture before full induction of antiviral
effectors by IFN produced in the culture. Thus, in situations
where IFNahR signaling and virus infection occur more-
or-less concurrently, RNase L may be capable of contrib-
uting to protection but its induction or induction of
2V5VOAS is prohibited by wild-type virus. With 24 h IFN
pretreatment, however, cells become infected when ISGs
are already fully induced, and antiviral effectors other than
RNase L may have been synthesized that wild-type but not
vhs-deficient virus can counteract. Interestingly, RNase L
also appears to affect wild-type HSV-2 in that its replication
was suppressed during high moi infection of RNase L/
MEFs. Under these conditions, the presence of RNase L
appears to have a positive impact on HSV-2 growth, but the
mechanism underlying the positive effect is not known.
Our results contrast with other work showing that HSV-1
replication is enhanced by 14-fold in MEFs lacking RNase
L (Harle et al., 2002b), but are consonant with data
indicating that HSV-1 replication is not enhanced in the
corneas of RNase L/ mice (Leib et al., 2000). RNase L
plays a role, however, in IFNh-induced suppression of
HSV-1 replication in trigeminal ganglia after corneal infec-
tion (Carr et al., 2003). Thus, the role of RNase L in
protecting diverse cell types in vivo from HSV infection
must be further elucidated.
The contribution of vhs to antagonism of the IFNah
response may differ somewhat between HSV-1 and HSV-2.
Although the HSV-2 vhs protein interferes with the type I
IFN response in MEFs and in mice (Murphy et al., 2003),
HSV-1 vhs effects on the IFNah response are minimal in
culture (Mossman et al., 2000) and in vivo (Leib et al.,
1999). In addition, we observed that HSV-2 replicates
equally well in wild-type 129 and PKR/ MEFs infected
at high moi, in contrast to previous reports showing en-
hanced replication of HSV-1 in PKR/ MEFs (Khabar et
al., 2000). These differences may relate to multiplicities of
infection used or passage history of the MEFs in the
different studies, or alternatively, support the possibility that
HSV-2 more effectively circumvents the effects of PKR than
does HSV-1. HSV-2 vhs activity is stronger and faster than
that of HSV-1 vhs (Everly and Read, 1997, 1999; Hill et al.,
1983). If vhs counteracts the type I IFN response through its
ribonuclease activity, the HSV-2 vhs protein may be more
apt than its HSV-1 counterpart to significantly decrease the
high levels of IFNah and ISG transcripts upregulated by
viral infection and receptor stimulation, respectively. The
HSV-2 vhs protein may therefore make a larger contribution
to overall defense against the IFNah response than HSV-1
vhs. HSV-2 mutants with deficiencies in combinations of
the IFN-resistance genes will be needed to establish the
specific contributions of each.Vhs activity is thought to promote virus replication by
alleviating competition from host mRNAs for translational
machinery and by promoting the switch to the next kinetic
class of viral transcripts (Strom and Frenkel, 1987). Because
vhs-deficient viruses replicate normally in IFN-unrespon-
sive cells, our data argue that a more important function of
vhs is immunoevasion. The rapid attenuation of vhs-defi-
cient HSV-2 during in vivo infection and the fact that
restoration occurs in IFNahR/ but not SCID mice iden-
tify IFNah or IFNah-stimulated antiviral proteins as func-
tionally relevant targets of vhs-mediated interference. We
have shown that vhs reduces IFN production and interferes
with activation of the antiviral state. Because vhs mediates
degradation of mRNAs and priming of the type I IFN
response is achieved by stimulating transcription of antiviral
response molecules, vhs has the opportunity to interfere
with induction of this host antiviral response. Thus, the
importance of vhs as a virulence factor may be in limiting
the amount mRNAs encoding type I IFNs and ISGs, thereby
inhibiting their synthesis. Examination of IFN and ISG
mRNA levels will be the focus of future experiments.Materials and methods
Cells and viruses
129 (wild-type), IFNahR/ (129 background), PKR/
(129 background), [B6 (wild-type), and RNase L/ (B6
background)] murine embryonic fibroblasts (MEFs) were
generated from embryos at 16–17 days of gestation. Cells
were cultured in DMEM supplemented with 10% FBS and
used through passage 5. One day before infection, cells were
split and seeded into 12-well plates.
Wild-type HSV-2 strain 333 (clone SB5), HSV-2 vhs-
deficient (333d41), and vhs rescue (333d41R) viruses were
obtained from Drs. David Leib and Tracy Smith. 333d41
has a targeted deletion in the UL41 gene between two XcmI
sites, resulting in a 939 base pair excision and complete lack
of vhs activity (Smith et al., 2002). 333d41R was con-
structed by recombination of the vhs ORF back into the d41
genome (Murphy et al., 2003). 333DTK (McDermott et al.,
1984) was the generous gift of Dr. Jim Smiley, and contains
a 180 base pair deletion in the tk ORF that abrogates tk
activity. Stocks were grown and simultaneously titered on
Vero cells (Morrison and Knipe, 1996).
In vitro infections
MEFmonolayers (approximately 2 105 cells/well) were
infected at moi of 10 (high moi) or 0.1 (low moi) with wild-
type, vhs, vhs rescue, and tk viruses for 1 h at 37 jC,
washed twice with PBS, and incubated further. Replicate
cultures were harvested by scraping at incremental times
postinfection and stored at 80 jC. Replication was quanti-
tated by standard plaque assay on Vero cell monolayers.
/ Virology 322 (2004) 158–167IFNab neutralization
129 MEFs were infected at low moi. Following infection,
various concentrations of polyclonal sheep anti-mouse
IFNah antibodies (Biosource) were included in the postin-
fection medium. Polyclonal sheep IgG and anti-IFNg anti-
bodies were used as negative controls. Cultures were
harvested 30 h postinfection and stored at 80 jC. Titers
were obtained by plaque assay on Vero cells.
IFNab pretreatment
IFNaA and IFNh (Biosource) concentrations were estab-
lished by titration against international standards (NIAID
Reference Reagent Repository). 129 MEFs were incubated
for 24 h with 100 or 1000 IU murine IFNaA or IFNh, or
mock-treated with media alone. After washing twice, cells
were infected at high moi. Cultures were harvested at 24
h postinfection and stored at 80 jC. Titers were obtained
by plaque assay on Vero cells.
IFNab bioassay
Cell-free supernatants from infected MEFs were collect-
ed in triplicate at 12 and 24 h postinfection and stored at
80 jC. Samples were serially diluted in threefold steps
into medium containing human anti-HSV antibodies and
transferred to 96-well plates previously seeded with 2  104
L929 cells. After 24 h incubation, cells were challenged
with the minimum dose of VSV for 100% CPE, and were
stained with crystal violet 48 h postchallenge. Optical
density of the remaining monolayer was quantitated at 570
nm using an EL340 microplate reader (Biotek). Units of IFN
produced by MEFs during infection were determined by
comparison to a standard curve generated from international
recombinant IFN standards.
Statistics
Significance of difference in IFN production or viral titer
at individual time points was determined by the t test.
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